Show simple item record

The impact of a clinical pharmacist in an interprofessional intensive care unit recovery clinic providing care to intensive care unit survivors

dc.contributor.authorMohammad, Rima A.
dc.contributor.authorEze, Chinwe
dc.contributor.authorMarshall, Vincent D.
dc.contributor.authorCoe, Antoinette B.
dc.contributor.authorCosta, Deena Kelly
dc.contributor.authorThompson, Amy
dc.contributor.authorPitcher, Mari
dc.contributor.authorHaezebrouck, Evan
dc.contributor.authorMcSparron, Jakob I.
dc.date.accessioned2022-11-09T21:18:33Z
dc.date.available2023-11-09 16:18:32en
dc.date.available2022-11-09T21:18:33Z
dc.date.issued2022-10
dc.identifier.citationMohammad, Rima A.; Eze, Chinwe; Marshall, Vincent D.; Coe, Antoinette B.; Costa, Deena Kelly; Thompson, Amy; Pitcher, Mari; Haezebrouck, Evan; McSparron, Jakob I. (2022). "The impact of a clinical pharmacist in an interprofessional intensive care unit recovery clinic providing care to intensive care unit survivors." Journal of the American College of Clinical Pharmacy 5(10): 1027-1038.
dc.identifier.issn2574-9870
dc.identifier.issn2574-9870
dc.identifier.urihttps://hdl.handle.net/2027.42/175097
dc.description.abstractIntroductionIntensive care unit (ICU) survivors are vulnerable to further health deterioration and medication-related problems (MRPs) with a high rate of potentially preventable hospital readmissions and late death. Therefore, it is critical to identify MRPs of ICU survivors post-hospitalization. ICU-recovery clinics (ICU-RCs) have been proposed as a potential mechanism to address the unmet needs of ICU survivors, and pharmacists should be key members of ICU-RCs.ObjectivesThe objective of this study was to evaluate the impact of a pharmacist in an interprofessional ICU-RC on MRPs.MethodsA retrospective cohort study was conducted in adult ICU survivors with sepsis/septic shock and/or respiratory failure. This study compared MRPs within 6 months of post-hospital discharge between intervention and control groups. The intervention group included patients who were seen by a pharmacist in an ICU-RC. MRPs and interventions between initial and 6-month follow-up visits in the intervention group were also evaluated.ResultsData were collected for 52 control and 52 intervention patients. There were no significant differences in baseline demographics and hospital characteristics between groups. Eighty-four MRPs were identified in the control vs 110 in the intervention group (P = .37). Half of patients in control and intervention groups had at least one MRP identified (P = .69). There was a significant decrease in mean number of MRPs at the 6-month follow-up visit (3.5 ± 1.7 with initial vs 2.4 ± 1.3 with follow-up visit; P = .025) in the intervention group. Almost all patients in initial and follow-up visits had at least one MRP.ConclusionsDedicated ICU-RC pharmacists in an interprofessional ICU-RC can assist with addressing and intervening on MRPs which could further impact clinical outcomes in ICU survivors.
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherpharmacist
dc.subject.otherpost-intensive care syndrome
dc.subject.othercritical illness
dc.subject.otherintensive care unit
dc.subject.otherintensive care unit recovery clinic
dc.subject.othermedication-related problems
dc.titleThe impact of a clinical pharmacist in an interprofessional intensive care unit recovery clinic providing care to intensive care unit survivors
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175097/1/jac51671_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175097/2/jac51671.pdf
dc.identifier.doi10.1002/jac5.1671
dc.identifier.sourceJournal of the American College of Clinical Pharmacy
dc.identifier.citedreferenceHirshberg EL, Wilson EL, Stanfield V, et al. Impact of critical illness on resource utilization: A comparison of use in the year before and after ICU admission. Crit Care Med. 2019; 47 ( 11 ): 1497 – 1504.
dc.identifier.citedreferenceHepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47: 533 – 543.
dc.identifier.citedreferenceErickson AK. Power of prediction: pharmacy-driven efforts at upmc shadyside strive to decrease hospital readmissions. Pharm Today. 2014; 20: 2 – 4.
dc.identifier.citedreferenceNeedham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit Care Med. 2012; 40: 502 – 509.
dc.identifier.citedreferenceSociety of Critical Care Medicine Critical Care Statistics. Available at: https://www.sccm.org/Communications/Critical-Care-Statistics. Accessed January 12, 2021.
dc.identifier.citedreferenceAmerican College of Clinical Pharmacy. Standards of practice for clinical pharmacists. https://www.accp.com/docs/positions/guidelines/standardsofpractice.pdf. Available from: Accessed June 1, 2020.
dc.identifier.citedreferenceSchofield-Robinson OJ, Lewis SR, Smith AF, McPeake J, Alderson P, Cochrane Effective Practice and Organisation of Care Group. Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors (review). Cochrane Database Syst Rev. 2018; 11: CD012701.
dc.identifier.citedreferenceJones LK, Greskovic G, Grassi DM, et al. Medication therapy disease management: Geisinger’s approach to population health management. Am J Health Syst Pharm. 2017; 74 ( 18 ): 1422 – 1435.
dc.identifier.citedreferenceHuggins EL, Bloom SL, Stollings JL, Camp M, Sevin CM, Jackson JC A clinic model: Post-intensive care syndrome and post-intensive care syndrome-family. AACN Adv Crit Care. 2016; 27 ( 2 ): 204 – 211.
dc.identifier.citedreferenceSevin CM, Bloom SL, Jackson JC, Wang L, Ely EW, Stollings JL. Comprehensive care of ICU survivors: Development and implementation of an ICU recovery center. J Crit Care. 2018; 46: 141 – 148.
dc.identifier.citedreferenceStollings JL, Bloom SL, Wang L, Ely EW, Jackson JC, Sevin CM. Critical care pharmacists and medication management in an ICU recovery center. Ann Pharmacother. 2018; 52 ( 8 ): 713 – 723.
dc.identifier.citedreferenceMacTavish P, Quasim T, Purdie C, et al. Medication-related problems in intensive care unit survivors: Learning from a multicenter program. Ann Am Thorac Soc. 2020; 17 ( 10 ): 1326 – 1329.
dc.identifier.citedreferenceBloom SL, Stollings JL, Kirkpatrick O, et al. Randomized clinical trial of an ICU recovery pilot program for survivors of critical illness. Crit Care Med. 2019; 47 ( 10 ): 1337 – 1345.
dc.identifier.citedreferenceMohammad RA, Betthauser KD, Korona RB, et al. Clinical pharmacist services within intensive care unit recovery clinics: An opinion of the critical care practice and research network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2020; 3: 1369 – 1379.
dc.identifier.citedreferenceTully AP, Hammond DA, Li C, Jarrell AS, Kruer RM. Evaluation of medication errors at the transition of care from an ICU to non-ICU location. Crit Care Med. 2019; 47 ( 4 ): 543 – 549.
dc.identifier.citedreferenceScales DC, Fischer HD, Li P, et al. Unintentional continuation of medications intended for acute illness after hospital discharge: A population-based cohort study. J Gen Intern Med. 2016; 31 ( 2 ): 196 – 202.
dc.identifier.citedreferenceBell CM, Brener SS, Gunraj N, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA. 2011; 306 ( 8 ): 840 – 847. https://doi.org/10.1001/jama.2011.1206.
dc.identifier.citedreferencePrescott HC, Angus DC. Enhancing recovery from sepsis. JAMA. 2018; 319 ( 1 ): 62 – 75.
dc.identifier.citedreferenceSociety of Critical Care Medicine. Post-Intensive Care Syndrome. Available at: https://www.sccm.org/MyICUCare/THRIVE/Post-intensive-Care-Syndrome. Accessed January 12, 2021.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.